drugset / Trial / NCT01293383

A Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of Healthy Japanese Male Subjects

NCT01293383 ↗

Phase 1 Completed 12 enrolled LEO Pharma Quintiles, Inc. · collab
RandomizedParallel-groupQuadruple-blindOther

Summary

The purpose of this trial is to to investigate the safety of LEO 90105 compared with its vehicle after multiple administration (twice daily, 5 days) in healthy Japanese male subjects.

Timeline

Start
2011-03
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject LEO 90105 Unknown — Topical

Indications

No indication recorded.